Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				Other				2003-1027 NCT00113334


2.		Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				M02-534 NCT00061659


3.		Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				M02-457 NCT00061672

Last Modified: 10/8/2004 First Published: 2/20/2004


4.		Phase II Randomized Study of ABT-510 in Patients With Locally Recurrent or Metastatic Renal Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				UCLA-0308112 ABBOTT-M02-428, NCT00080704

Last Modified: 1/11/2008 First Published: 1/10/2008


5.		Phase II Study of ABT-510 in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				NCI				MAYO-MC0375 MC0375, NCT00602199

Last Modified: 8/21/2007 First Published: 1/6/2006


6.		Phase I Study of ABT-510 and Bevacizumab in Patients With Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				DUMC-6074-05-7R1ER DUMC-6074, NCT00276562

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute